What to know
CDC’s Division of Cancer Prevention and Control conducts and supports studies to reduce cancer and eliminate health disparities.
Overview
CDC contributes data and scientific expertise on:
- Cancer prevention and risk behaviors.
- The quality and appropriate use of cancer screening.
- The cost and cost-effectiveness of cancer control programs.
- Health and wellness after a cancer diagnosis.
- Efforts to advance health equity.
CDC's latest cancer research
- Characterizing screening champions in CDC’s Colorectal Cancer Control Program
- Public understanding of and engagement with community health workers and promotores de salud: findings from two national surveys
- A comparison of family health history of breast cancer, colorectal cancer, and diabetes in self-reported survey and electronic health records data, All of Us Research Program
- Cost of colorectal cancer screening in two tribal health organizations in Alaska
- Interventions to increase colorectal cancer screening uptake in rural settings: a scoping review
- Sustainability of evidence-based interventions implemented in CDC's Colorectal Cancer Control Program
- A multimodal analysis of resource allocation across U.S. cancer registries
- Enrollment in children's oncology group's clinical trials: population-based linkage with the national childhood cancer registry
- Breast, cervical, and colorectal cancer screening prevalence in the US-Affiliated Pacific Islands
- Estimating the long-term health impact and program cost-effectiveness of providing direct screening services to low-income, medically underserved patients through the Colorectal Cancer Control Program (CRCCP)
- Health-related quality of life among prostate cancer survivors with metastatic disease and non-metastatic disease and men without a cancer history in the USA
- Estimated health outcomes of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program by race/ethnicity
- Improving quality of mortality estimates among non-Hispanic American Indian and Alaska Native people, 2020
- Annual Report to the Nation on the Status of Cancer, featuring state-level statistics after the onset of the COVID-19 pandemic
- Patterns and differences in lung cancer treatment: United States, 2015–2020
- Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling
- Social risk factors screening preferences among breast and prostate cancer survivors: a qualitative study
- Differences in lung cancer death rates by rural vs. urban status in comparison to all-cancer death rates—United States, 1999–2020